ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

1978, ’79 budget Projections By Research Programs

November 25, 1977

DCT Program Cutbacks Planned as Research Stressed In 4 Cancers

February 26, 1993

Smaller Ultrasound-Guided Biopsy Needle Safe, Effective, For Suspected Breast Cancer

May 30, 2003

Most of NCI’s Increase For Breast Cancer to Fund Grants: Broder

May 21, 1993

NCI To Fund 3,232, Research Project Grants In Fiscal 1993

January 15, 1993

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011